C&Y Pharmaceutical plans to launch a restricted stock incentive plan of no more than 9.15 million shares
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, C&Y Pharmaceutical disclosed the draft of the 2025 Restricted Stock Incentive Plan, which proposes to grant a total of no more than 9.15 million restricted shares to the incentive recipients, accounting for 3.68% of the company's total share capital at the time of the announcement of this incentive plan draft. Among them, 7.95 million shares will be granted in the first grant, with a total of 171 incentive recipients, and the grant price (including reserves) is set at 5.60 yuan/share
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments